Jane Street Group, LLC Relmada Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$16.72 - $26.99 $578,512 - $933,854	34,600 New	34,600 $934,000
Q1 2021 May 18, 2021	SELL	$31.52 - $39.28 $892,016 - $1.11 Million	-28,300 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$29.88 - $39.8 $845,604 - $1.13 Million	28,300 New	28,300 $908,000
Q3 2020 Nov 17, 2020	SELL	$34.42 - $43.78 $1.55 Million - $1.97 Million	-44,900 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$31.59 - $49.98 $1.42 Million - $2.24 Million	44,900 New	44,900 $2.01 Million

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $83M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.